Different RONS Generation in MTC-SK and NSCL Cells Lead to Varying Antitumoral Effects of Alpha-Ketoglutarate+5-HMF

被引:3
作者
Greilberger, Joachim [1 ]
Erlbacher, Katharina [2 ]
Stiegler, Philipp [3 ]
Wintersteiger, Reinhold [4 ]
Herwig, Ralf [5 ,6 ]
机构
[1] Schwarzl Med Ctr, Inst Laborwissenschaften Dr Greilberger, A-8301 Lassnitzhoehe, Austria
[2] HG Pharm GmbH, A-6365 Kirchberg In Tirol, Austria
[3] Med Univ Graz, Div Transplantat Surg, A-8010 Graz, Austria
[4] Karl Franzens Univ Graz, Inst Pharmaceut Sci, Dept Pharmaceut Chem, A-8010 Graz, Austria
[5] Labs PD Dr R Herwig, D-80337 Munich, Germany
[6] Heimerer Coll, Pristina 10000, Kosovo
关键词
medullary thyroid cancer cell (MTS-SK); non-small-cell lung carcinoma (NSCLC); alpha-ketoglutarate (aKG); 5-hydroxy-methyl-furfural (5-HMF); carbonylated proteins of cell membrane (CP); reactive oxygen and nitrogen species (RONS); cell proliferation; mitochondrial activity; caspase activity; THYROID ASSOCIATION GUIDELINES; IN-VITRO ANTIOXIDANT; ALPHA-KETOGLUTARATE; CANCER; MANAGEMENT; CONVERSION; CARCINOMA; SUCCINATE;
D O I
10.3390/cimb45080410
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Carbonylated proteins (CPs) serve as specific indicators of increased reactive oxygen and nitrogen species (RONS) production in cancer cells, attributed to the dysregulated mitochondrial energy metabolism known as the Warburg effect. The aim of this study was to investigate the potential of alpha-ketoglutarate (aKG), 5-hydroxymethylfurfural (5-HMF), and their combination as mitochondrial-targeting antioxidants in MTC-SK or NCI-H23 cancer cells. Methods: MTC-SK and NCI-H23 cells were cultured in the absence or presence of varying concentrations (0-500 mu g/mL) of aKG, 5-HMF, and the combined aKG + 5-HMF solutions. After 0, 24, 48, and 72 h, mitochondrial activity, cancer cell membrane CP levels, cell growth, and caspase-3 activity were assessed in aliquots of MTC-SK and NCI-H23 cells. Results: The mitochondrial activity of MTC-SK cells exhibited a concentration- and time-dependent reduction upon treatment with aKG, 5-HMF, or the combined aKG + 5-HMF. The half-maximal inhibitory concentration (IC50%) for mitochondrial activity was achieved at 500 mu g/mL aKG, 200 mu g/mL 5-HMF, and 200 mu g/mL aKG + 66.7 mu g/mL 5-HMF after 72 h. In contrast, NCI-H23 cells showed a minimal reduction (10%) in mitochondrial activity even at the highest combined concentration of aKG + 5-HMF. The CP levels in MTC-SK cells were measured at 8.7 nmol/mg protein, while NCI-H23 cells exhibited CP levels of 1.4 nmol/mg protein. The combination of aKG + 5-HMF led to a decrease in CP levels specifically in MTC-SK cells. The correlation between mitochondrial activity and CP levels in the presence of different concentrations of combined aKG + 5-HMF in MTC-SK cells demonstrated a linear and concentration-dependent decline in CP levels and mitochondrial activity. Conversely, the effect was less pronounced in NCI-H23 cells. Cell growth of MTC-CK cells was reduced to 60% after 48 h and maintained at 50% after 72 h incubation when treated with 500 mu g/mL aKG (IC50%). Addition of 500 mu g/mL 5-HMF inhibited cell growth completely regardless of the incubation time. The IC50% for 5-HMF on MTC-CK cell growth was calculated at 375 mu g/mL after 24 h incubation and 200 mu g/mL 5-HMF after 72 h. MTC-SK cells treated with 500 mu g/mL aKG + 167 mu g/mL 5-HMF showed no cell growth. The calculated IC50% for the combined substances was 250 mu g/mL aKG + 83.3 mu g/mL 5-HMF (48 h incubation) and 200 mu g/mL aKG + 66.7 mu g/mL 5-HMF (72 h incubation). None of the tested concentrations of aKG, 5-HMF, or the combined solution had any effect on NCI-H23 cell growth at any incubation time. Caspase-3 activity increased to 21% in MTC-CK cells in the presence of 500 mu g/mL aKG, while an increase to 59.6% was observed using 500 mu g/mL 5-HMF. The combination of 500 mu g/mL aKG + 167.7 mu g/mL 5-HMF resulted in a caspase-3 activity of 55.2%. No caspase-3 activation was observed in NCI-H23 cells when treated with aKG, 5-HMF, or the combined solutions. Conclusion: CPs may serve as potential markers for distinguishing between cancer cells regulated by RONS. The combination of aKG + 5-HMF showed induced cell death in high-RONS-generating cancer cells compared to low-RONS-generating cancer cells.
引用
收藏
页码:6503 / 6525
页数:23
相关论文
共 33 条
[1]   Specific protein carbonylation in human breast cancer tissue compared to adjacent healthy epithelial tissue [J].
Aryal, Baikuntha ;
Rao, V. Ashutosh .
PLOS ONE, 2018, 13 (03)
[2]   Vicenin-2 acts as a radiosensitizer of the non-small cell lung cancer by lowering Akt expression [J].
Baruah, Taranga Jyoti ;
Kma, Lakhon .
BIOFACTORS, 2019, 45 (02) :200-210
[3]   Mitochondrial succinate is instrumental for HIF1α nuclear translocation in SDHA-mutant fibroblasts under normoxic conditions [J].
Brière, JJ ;
Favier, J ;
Bénit, P ;
El Ghouzzi, V ;
Lorenzato, A ;
Rabier, D ;
Di Renzo, MF ;
Gimenez-Roqueplo, AP ;
Rustin, P .
HUMAN MOLECULAR GENETICS, 2005, 14 (21) :3263-3269
[4]   Medullary thyroid carcinoma beyond surgery: advances, challenges, and perspectives [J].
Ceolin, Lucieli ;
da Silveira Duval, Marta Amaro ;
Benini, Antonio Felippe ;
Ferreira, Carla Vaz ;
Maia, Ana Luiza .
ENDOCRINE-RELATED CANCER, 2019, 26 (09) :R499-R518
[5]  
Fiaschi Tania, 2012, Int J Cell Biol, V2012, P762825, DOI 10.1155/2012/762825
[6]   Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].
Filetti, S. ;
Durante, C. ;
Hartl, D. ;
Leboulleux, S. ;
Locati, L. D. ;
Newbold, K. ;
Papotti, M. G. ;
Berruti, A. .
ANNALS OF ONCOLOGY, 2019, 30 (12) :1856-1883
[7]   Alpha-Ketoglutarate and 5-HMF: A Potential Anti-Tumoral Combination against Leukemia Cells [J].
Greilberger, Joachim ;
Herwig, Ralf ;
Greilberger, Michaela ;
Stiegler, Philipp ;
Wintersteiger, Reinhold .
ANTIOXIDANTS, 2021, 10 (11)
[8]   Alpha-Ketoglutarate: A Potential Inner Mitochondrial and Cytosolic Protector against Peroxynitrite and Peroxynitrite-Induced Nitration? [J].
Greilberger, Joachim ;
Greilberger, Michaela ;
Wintersteiger, Reinhold ;
Zangger, Klaus ;
Herwig, Ralf .
ANTIOXIDANTS, 2021, 10 (09)
[9]   Hallmarks of Cancer: New Dimensions [J].
Hanahan, Douglas .
CANCER DISCOVERY, 2022, 12 (01) :31-46
[10]   2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer [J].
Haugen, Bryan R. ;
Alexander, Erik K. ;
Bible, Keith C. ;
Doherty, Gerard M. ;
Mandel, Susan J. ;
Nikiforov, Yuri E. ;
Pacini, Furio ;
Randolph, Gregory W. ;
Sawka, Anna M. ;
Schlumberger, Martin ;
Schuff, Kathryn G. ;
Sherman, Steven I. ;
Sosa, Julie Ann ;
Steward, David L. ;
Tuttle, R. Michael ;
Wartofsky, Leonard .
THYROID, 2016, 26 (01) :1-133